DENVER and BURLINGTON, Vt., April 5, 2016 /PRNewswire/ -- As part of its ongoing mission to reach as many patients as possible with its award-winning cannabis products, Mary's Medicinals today announced that it has teamed with Champlain Valley Dispensary to bring its transdermal patches to authorized medical cannabis patients in Vermont.
"With more than two-dozen states allowing the medical use of cannabis in some form, the potential benefits of this plant are clear," said Nicole Smith, CEO of Mary's Medicinals. "However, some patients are hesitant to use many of the traditional cannabis products on the market today that involve smoking, dabbing or eating sugary candies. With our clinical grade delivery methods and accurate dosing mechanisms, patients can find relief that is more effective, more reliable and more targeted than anything else available today."
Available in THC Indica, THC Sativa, THCa, CBN, CBD and CBD:THC 1:1, Mary's flagship patches are born out of a commitment to accurate dosing and the application of advanced delivery methods. Mary's patches are 2x2 squares, easy to use, and adhere simply to any veinous area for up to 12 hours of relief. Every batch of Mary's Medicinals products is laboratory tested for quality, accuracy and consistency.
"Mary's has built a reputation for creating innovative, trusted products that are transforming how people view and use cannabis," said Shayne Lynn, executive director, Champlain Valley Dispensary and Southern Vermont Wellness, Inc., "We're thrilled to collaborate with Mary's to bring these products to Vermont patients that are seeking reliable medical cannabis options."
Mary's products are currently available in Vermont, California, Washington, Oregon, Arizona and Colorado. To find the location nearest you, visit: http://www.marysmedicinals.com/find-marys-products/. Look for Mary's products in additional states later this year.
About Mary's Medicinals:
Mary's Medicinals is a wellness company innovating at the intersection of engineering and horticulture. Mary's is focused on transforming how people view and utilize cannabis, developing products that isolate the benefits of cannabis and other vital plant extracts for optimum patient care. More information is available at: www.marysmedicinals.com
The statements made regarding these products have not been evaluated by the Food and Drug Administration. The efficiency of these products has not been confirmed by FDA-approved research. These products are not intended to diagnose, treat, cure or prevent any disease. All information presented here is not meant as a substitute for or alternative to information from health care practitioners. If you are taking any medication or are under treatment for any disease, please consult your health care professional about potential interactions or other possible complications before using these products. The Federal Food, Drug and Cosmetic Act requires this notice.
Supporting Resources:
- Follow @Marysmedicinals on:
- Facebook: facebook.com/marymedicinalsofficial
- Twitter: https://twitter.com/marysmedicinals
- Media Kit
Press Contact:
Graham Sorkin
[email protected]
855-420-6334
Logo - http://photos.prnewswire.com/prnh/20160404/351382LOGO
SOURCE Mary’s Medicinals
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article